Healthcare Business News
 

House to vote this week on user-fee programs


By Jessica Zigmond
Posted: May 28, 2012 - 12:01 am ET
Tags:

House members are scheduled to vote Wednesday on the Food and Drug Administration Reform Act to reauthorize the drug and user-fee programs that would expire later this year and authorize new generic and biosimilar user-fee programs.

Scheduled to expire Sept. 30, the drug and device user-fee programs allow the FDA to collect fees from the pharmaceutical and medical device industries in exchange for agreeing to meet performance goals. The House Energy and Commerce Committee unanimously approved Rep. Fred Upton's (R-Mich.) bill (PDF) earlier this month.

Advertisement | View Media Kit

 

Meanwhile, the Senate last week passed its own legislation to reauthorize drug and device user-fee programs and authorize new generic and biosimilar user-fee programs in a vote of 96 to 1.


What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.